10.31.16 | Urology
SWHR Welcomes New Member to Urology Network
SWHR is pleased to welcome Mary Happel Palmer, RN, PhD, FAAN, AGSF, to the Interdisciplinary Network on Urological Health in Women.
10.28.16 | Research and Clinical Trials
SWHR Cohosts Sex Differences Conference at University of Colorado
SWHR cohosted the National Conference on Women’s Health Research with University of Colorado Anschutz Medical Campus’ Center for Women’s Health Research (CWHR), titled “Sex Differences Across the Lifespan: A Focus on Metabolism.”
7.5.16
STDs are Incredibly Common – So Why The Stigma?
Despite recommendations from the CDC and the United States Preventive Services Task Force (USPSTF) for annual chlamydia and gonorrhea screening for sexually active women younger than 25, experts are concerned that not enough women get tested and therefore don’t know they are infected.
6.15.16
SWHR Attends Annual OSSD Meeting
SWHR attended the 10th annual Organization for the Study of Sex Differences (OSSD) meeting May 23-25, 2016, in Philadelphia.
1.12.16 | Urology
SWHR Announces Urology Network Chairs
SWHR selected two chairs to head its Interdisciplinary Network on Urological Health In Women, Dr. Margot Damaser and Dr. Elizabeth Mueller.
12.17.15
SWHR Founder Named National Academy of Inventors Fellow
SWHR founder, Florence P. Haseltine, PhD, MD, has been named a National Academy of Inventors (NAI) Fellow.
12.15.15 | Research and Clinical Trials
Second Annual CURE-UAB Meeting Emphasizes Need For Public Awareness, Research Funding
Dr. Liliana Losada, associate director of scientific programs at SWHR recently attended the Second International Congress on Underactive Bladder(CURE-UAB) in Denver, Colorado.
7.8.15 | Research and Clinical Trials
Congressional Briefing to Explore Biological Sex Differences’ Impact on Medical Research
Women’s health leaders press for female subjects to be included in basic research studies
6.9.15 | Alzheimer's Disease
SWHR Leads Scientific Roundtable on Alzheimer’s Disease
SWHR held its second interdisciplinary roundtable on understanding sex and gender differences in Alzheimer’s disease May 28-29, 2015 at the Hyatt Regency Crystal City in Arlington, Va.
6.5.15
Flibanserin Nears Approval, But Much Work Remains
The Food and Drug Administration (FDA) Advisory Committee has made history for women by recommending approval of Sprout Pharmaceuticals’ twice-rejected female libido drug Flibanserin.
